| | Conditions & Treatments | Osteoporosis

Osteoporosis as a Homeostatic Imbalance: Bone Remodeling Gone Wrong

Osteoporosis is a systemic skeletal disease of low bone mass and microarchitectural deterioration → fragility fractures. It represents a homeostatic imbalance in bone remodeling.

Normal Bone Remodeling (Coupled Process)

Resorption: Osteoclasts dissolve mineral, degrade collagen (∼3 weeks).
Reversal: Monocytes prepare surface.
Formation: Osteoblasts lay osteoid → mineralize (∼3 months).
Balance: Formation = resorption → stable bone mass.

Osteoporosis: Uncoupling

Resorption > formation → net bone loss per remodeling cycle.
Remodeling rate may be high (postmenopausal) or low (senile) — but balance negative.
Microarchitecture: trabecular thinning, loss of connectivity, cortical porosity.

Drivers of Imbalance

Diagnosis & Treatment

DXA: T-score ≤–2.5 (spine/hip) or fragility fracture.
FRAX: 10-year major osteoporotic/hip fracture probability.
Rx: Bisphosphonates (alendronate, zoledronate), denosumab, anabolics (teriparatide, romosozumab, abaloparatide) for high risk.
Foundation: Ca²⁺ 1200 mg, vit D 800–2000 IU, weight-bearing exercise, fall prevention.

Bone remodeling imbalance is reversible to a degree — early intervention preserves architecture.

Osteoporosis - Related Articles

Factor	Mechanism
Estrogen loss (menopause)	↑ RANKL/OPG ratio → osteoclastogenesis; ↓ osteoblast apoptosis
Aging	↓ osteoblast function, ↑ marrow adiposity, ↓ mechanosensing
Glucocorticoids	↓ osteoblastogenesis, ↑ osteoclast life, ↓ Ca²⁺ absorption, ↓ sex steroids
Secondary causes	Hyperthyroidism, hyperparathyroidism, celiac, RA, myeloma, drugs (aromatase inhibitors, GnRH agonists, PPIs chronic)
Lifestyle	Smoking, alcohol, low Ca²⁺/vit D, inactivity, low BMI